Tamera Anderson-Hanna reflects on survivorship, redefining life with family, travel, purpose and giving back while embracing ...
This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat various cancers and autoimmune conditions such as rheumatoid arthritis and ...
FDA IND clearance enables a phase 1b evaluation of SP16 in chemotherapy-induced pain and peripheral neuropathy, with ...
A twofold standardized incidence ratio for subsequent primary neoplasms in 5-year survivors translated to 35.7 excess cases ...
Elraglusib plus chemotherapy doubled one-year survival in metastatic pancreatic cancer, showing improved outcomes in a phase ...
After an aggressive breast cancer diagnosis, psychologist Loraine Alderman retires to bridge gaps in patient literature ...
Most surgical candidates, including many with prior thoracic or abdominal operations, can undergo minimally invasive ...
Metastatic breast cancer denotes distant organ involvement (e.g., liver, brain, bone) and typically changes therapeutic goals ...
PDS01ADC is a tumor-targeted IL-12 immunocytokine designed to activate the immune system directly within the tumor ...
Fraser Symmans explains how ctDNA is replacing CTCs to monitor breast cancer, detect mutations and track minimal residual ...
MacDonald draws on her unique dual perspective to advocate for better patient education. Despite a decade of medical ...
In this segment, Dr. Morrison discusses the clinical evidence supporting subcutaneous immunotherapy and explains the concept ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results